Business ❯ Pharmaceuticals

Manufacturing

Investment Job Creation Facilities Active Pharmaceutical Ingredients Drug Production Drug Development Safety Protocols Biologics Safety Regulations Domestic Production

Eli Lilly Breaks Ground on $6.5 Billion Houston Campus to Make Oral GLP-1 Pill

The company says the Generation Park site will boost domestic drug production and train local workers while state incentives support the deal.

Bristol Myers Squibb to Build $2.3 Billion Modular Manufacturing Campus in Houston

Lilly and Resilience Announce $750 Million Ohio Expansion for KwikPen and Injectables

Red Tech Brings SHINVA and SMA Pharmaceutical Equipment to Brazil

Katwijk Council Gives Provisional Backing to Eli Lilly Factory After €100 Million Infrastructure Deal

TheraNyM Biologics Opens ₹1,200 Crore Biologics Plant Near Hyderabad

Grifols Starts Building 80,000 m² Plasma Complex in Lliçà de Vall

Eli Lilly Pours $4.5 Billion Into Indiana Plants, Opens Genetic-Medicine Site

Novartis to Close Wehr Plant by 2028, About 220 Jobs at Risk

Nosch Labs Reactor Blast Injures Nine on Labour Day

AbbVie to Build $1.4 Billion Injectable-Medicines Campus in Durham, N.C.

UCB Picks Georgia’s Rowen for $2 Billion Biologics Campus

Novo Nordisk Invests €432 Million to Expand Athlone Plant for Oral GLP-1 Tablets

Blue Jet Healthcare to Break Ground Today on Rs 2,300-Crore Pharma Plant in Andhra Pradesh

Novartis to Build 46,000‑Square‑Foot Radioligand Therapy Plant in Denton, Texas

AbbVie to Invest $380 Million in Two North Chicago API Plants

Toluene Tank Explodes at Ercros’s Aranjuez Plant With No Injuries Reported

Eli Lilly Chooses Pennsylvania for $3.5 Billion Plant to Produce Weight-Loss Injectables

Eli Lilly Picks Lehigh Valley for $3.5 Billion Plant to Make Next-Gen Weight-Loss Drugs

Tanya Mittal Denies '150 Bodyguards' Claim, Opens Pharma Factory to Media